Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value:
$23.10M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tourmaline Bio Inc741,691741,6910$15.04M$11.28M48.83%-$3.76M
Korro Bio, Inc.(KRRO)368,085368,0850$14.01M$6.41M27.74%-$7.60M
Jasper Therapeutics, Inc.(JSPR)928,964928,9640$19.86M$3.99M17.29%-$15.87M
Hillevax Inc372,615372,6150$771.3K$540.3K2.34%-$231.0K
Ventyx Biosciences Inc412,225412,2250$902.8K$474.1K2.05%-$428.7K
Kezar Life Sciences Inc
COM NEW
82,87182,8710$556.9K$404.4K1.75%-$152.5K
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q1 2025 | TickerTrail